Publications by authors named "Mike Comer"

Claim this Profile
A
A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Andrew J Massey, Douglas S Williamson, Helen Browne, James B Murray, Pawel Dokurno, Mike Comer

Cancer Chemother Pharmacol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.
Simon T Bedford, Karen R Benwell, Teresa Brooks, Ijen Chen, Mike Comer

Bioorg Med Chem Lett· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Roger J Gillespie, Samantha J Bamford, Ruth Botting, Mike Comer, Sarah Denny

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].
Victoria Boswell-Smith, Domenico Spina, Alec W Oxford, Mike B Comer, Esther A Seeds

J Pharmacol Exp Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis